Merck Pulls Vioxx Off the Market

In a move that surprised a lot of business people, but not me, Merck has pulled the popular anti-inflammatory drug Vioxx off the market today, citing a study they were conducting that shows patients taking the drug face twice the risk of heart attacks compared to those taking a placebo. According to a FDA press release, "Although the risk that an individual patient would have a heart attack or stroke related to Vioxx is very small, the study that was halted suggests that, overall,...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports